{
    "code": "52R00097",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52R00097",
    "time": "2022-04-29 05:52:37",
    "許可證字號": "衛部藥輸字第R00097號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/03\/30",
    "發證\/登錄日期": "106\/03\/30",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA052R0009700",
    "中文品名": "腦血流造影凍晶注射劑500微克",
    "英文品名": "Medi-Exametazime 500 micrograms Kit for radiopharmaceutical preparation",
    "適應症": "局部腦血流醫學造影診斷",
    "劑型": "243凍晶注射劑",
    "包裝": "每紙盒六瓶type I玻璃瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "新使用劑量",
    "監視期限": "",
    "主成分略述": "EXAMETAZIME",
    "限制項目": "02輸　入",
    "申請商名稱": "1432501100  臺灣新吉美碩股份有限公司",
    "申請商地址": "台北市大安區復興南路一段237號11樓",
    "主製造廠": [
        {
            "": "HUNGARY",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "3668003700",
            "成分名稱": "EXAMETAZIME",
            "含量描述": "Exametazime (d,1-HMPAO d, 1-hexamethylpropylene amine oxime)",
            "含量": "0.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Medi-Exametazime仿單-106-05-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52R00097&Seq=001&Type=9"
        },
        {
            "title": "中文標籤-106-05-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52R00097&Seq=002&Type=8"
        },
        {
            "title": "外盒-106-05-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52R00097&Seq=001&Type=8"
        }
    ]
}